Shanghai Kehua Bio-engineering Co (SZSE:002022) Accounts Payable & Accrued Expense : ¥626 Mil (As of Jun. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Shanghai Kehua Bio-engineering Co Accounts Payable & Accrued Expense?

Shanghai Kehua Bio-engineering Co's quarterly accounts payable & accrued expense declined from Dec. 2023 (¥708 Mil) to Mar. 2024 (¥644 Mil) and declined from Mar. 2024 (¥644 Mil) to Jun. 2024 (¥626 Mil).

Shanghai Kehua Bio-engineering Co's annual accounts payable & accrued expense increased from Dec. 2021 (¥701 Mil) to Dec. 2022 (¥1,628 Mil) but then declined from Dec. 2022 (¥1,628 Mil) to Dec. 2023 (¥708 Mil).

Shanghai Kehua Bio-engineering Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shanghai Kehua Bio-engineering Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Kehua Bio-engineering Co Accounts Payable & Accrued Expense Chart

Shanghai Kehua Bio-engineering Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

390.58

709.53

701.06

1,628.43

708.42

Shanghai Kehua Bio-engineering Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															828.14	685.62	708.42	643.77	625.79

Shanghai Kehua Bio-engineering Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shanghai Kehua Bio-engineering Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai Kehua Bio-engineering Co Ltd (SZSE:002022) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1189 Qinzhou North Road, Xuhui District, Shanghai, CHN, 200233

Website

http://www.skhb.com

Shanghai Kehua Bio-engineering Co Ltd is a developer, manufacturer, and marketer of in-vitro diagnostics business in China. Its products are mainly offered in two primary business segments: Diagnostic Reagents and Diagnostic Laboratory Instruments. Its products include diagnostic reagents, such as enzyme-immunoassay kits, clinical chemistry reagents, PCR kits, and rapid test kits and lab-instruments comprising chemistry analyzers, microplate washers/readers, electrolyte analyzers, and nucleic acid extractors.

Executives

Li Ming	Executives
He Jian Wen	Executives
Ji Yu Ming	Supervisors
Li Ji	Executives
Sha Li Wu	Director
Wang Man	Directors, executives
Tang Wei Guo	Director

Shanghai Kehua Bio-engineering Co Headlines

No Headlines